Skip to Content
Center for International Blood and Marrow Transplant Research

IN17-01b

Main Content

Incidence and impact of non-cytomegalovirus herpes viral infection in haploidentical and matched sibling donors receiving post-transplant cyclophosphamide: A CIBMTR analysis.

Study #: IN17-01b

Study Status: Published

Presentation(s)

2020, TCT Meetings (Poster)

Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome.

Citation

Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveir S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales M-A, Riches M.

Transplantation and Cellular Therapy. 2022, Jan 01: 2(1): 2(1):48.e1-48.e10. doi: 10.1016/j.jtct.2021.09.015. Epub 2021, Sep 26. PMCID:PMC9717499.

PubMed

PMID: 34587551

Abstract